Fulminant mulch pneumonitis in undiagnosed chronic granulomatous disease: A medical emergency

Clinical Pediatrics

Volumn 49, Issue 12, 2010, Pages 1143-1146

  Ameratunga, Rohan ^a   Woon, See Tarn ^a   Vyas, Julian ^b   Roberts, Sally ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; IMMUNOGLOBULIN; STEROID; VORICONAZOLE;

ADOLESCENT; ANAMNESIS; ARTICLE; ASPERGILLOSIS; BRONCHOSCOPY; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; EXTRACORPOREAL OXYGENATION; FEMALE; GENE MUTATION; GRANULOCYTE TRANSFUSION; HUMAN; MULCH; PNEUMONIA; THORAX RADIOGRAPHY;

ADOLESCENT; ASPERGILLUS FUMIGATUS; DIAGNOSIS, DIFFERENTIAL; EMERGENCIES; FATAL OUTCOME; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; PNEUMONIA; PULMONARY ASPERGILLOSIS; X-RAYS;

EID: 78650206416     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922810370057     Document Type: Article

References (12)

1. Bridges RA, Berendes H., Good RA A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome. AMA J Dis Child. 1959 ; 97: 387-408.
2. Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000 ; 79: 155-169.
3. Stasia MJ, Li XJ Genetics and immunopathology of chronic granulomatous disease. Semin Immunopathol. 2008 ; 30: 209-235.
4. Matute JD, Arias AS, Wright N., et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009 ; 114: 3309-3315.
5. Ameratunga R., Woon ST Customised molecular diagnosis of primary immune deficiency disorders in New Zealand: an efficient strategy for a small developed country. N Z Med J. 2009 ; 122: 46-53.
6. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med. 1991 ; 324: 509-516.
7. Ott MG, Seger R., Stein S., Siler U., Hoelzer D., Grez M. Advances in the treatment of chronic granulomatous disease by gene therapy. Curr Gene Ther. 2007 ; 7: 155-161.
8. Cross AR, Yarchover JL, Curnutte JT The superoxidegenerating system of human neutrophils possesses a novel diaphorase activity. Evidence for distinct regulation of electron flow within NADPH oxidase by p67-phox and p47-phox. J Biol Chem. 1994 ; 269: 21448-21454.
9. Kabuki T., Kawai T., Kin Y., et al. A case of Williams syndrome with p47-phox-deficient chronic granulomatous disease [in Japanese]. Nihon Rinsho Meneki Gakkai Kaishi. 2003 ; 26: 299-303.
10. Siddiqui S., Anderson VL, Hilligoss DM, et al. Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clin Infect Dis. 2007 ; 45: 673-681.
11. Alvarado CS, Gandara A., Flores C., et al. Seasonal changes in airborne fungi and bacteria at a dairy cattle concentrated animal feeding operation in the southwest United States. J Environ Health. 2009 ; 71: 40-44.
12. Boehmer TK, Jones TS, Ghosh TS, McCammon CS, Vogt RL Cluster of presumed organic dust toxic syndrome cases among urban landscape workers-Colorado, 2007. Am J Ind Med. 2009 ; 52: 534-538.